Treating patients with respiratory disease who smoke. - Wikidata - awgldk - TriplyDB

Treating patients with respiratory disease who smoke.

Treating patients with respiratory disease who smoke.

http://www.wikidata.org/entity/Q37362600

about

Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function Effects of long-term smoking on the activity and mRNA expression of CYP isozymes in rats.Challenges of treating asthma in people who smoke.

P2860

Q33757657-3B2CCC12-9F29-49E5-B8A9-FF4218FEEE16 Q36254435-8F2AD23A-21AC-4850-9B78-EC34C2A1028D Q37733518-BCC2CAE4-E293-48EC-B892-8F97D9F794DC

P2860

Treating patients with respiratory disease who smoke.

http://www.wikidata.org/entity/Q37362600

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Treating patients with respiratory disease who smoke.

@en

Treating patients with respiratory disease who smoke.

@nl

type

label

Treating patients with respiratory disease who smoke.

@en

Treating patients with respiratory disease who smoke.

@nl

prefLabel

Treating patients with respiratory disease who smoke.

@en

Treating patients with respiratory disease who smoke.

@nl

P1433

Q37362600-D650E7BF-585A-4F19-A3CE-24475FAB25FF

P1476

Q37362600-B4AAF841-492D-45B9-80DD-EA853AA43168

P2093

Q37362600-2B478151-ABB2-423B-B12F-18C6ABFF44EA

Q37362600-7475D92D-F7C6-4C23-9349-2CA5EB14E0EF

Q37362600-78583AC3-6453-4C2A-899E-C98B96FCEB51

P2860

Q37362600-0564EC1D-9757-4582-9ACE-27A1072A8A5B

Q37362600-0AE4348A-F457-426B-AD4E-52B94344EA17

Q37362600-0E93F2E6-2CCF-4110-A91D-720552876022

Q37362600-0F940C07-3A90-4FA6-82F5-88AF9A9EC936

Q37362600-10F0133B-7508-4DFD-9745-03499B93CE2C

Q37362600-1C3D3DF7-0FAE-48F3-B461-2ABFE67600F5

Q37362600-1CBCFD0E-2F57-42E7-91D4-9728A1732709

Q37362600-29EA8653-7681-4AF3-B43B-7AF0B41A20E5

Q37362600-2F177BFE-7846-42B2-83A0-F3F9F37A8D2E

Q37362600-2FE4064E-9C02-49C1-AD09-A21C853BE2DD

P304

Q37362600-CB503C1E-7DDB-4C4A-B1A5-8C753C2AE6AC

P31

Q37362600-6E355D0B-6255-4B1D-8103-06BF128AEED2

P356

Q37362600-9D0F439F-55E0-41EF-81D5-2AD3814DB0D2

P433

Q37362600-42CC95A4-3D26-40CF-8113-61D7D5564064

P478

Q37362600-9E0AE12A-9E04-4652-979D-D3C8738317C8

P577

Q37362600-E0A4B186-4E5D-48A1-8BA1-F28176F543C2

P698

Q37362600-97BAD4B4-2816-40AE-91E3-C4FFE0D869DB

P356

1753465808089697

P1433

Therapeutic advances in respiratory disease

P1476

Treating patients with respiratory disease who smoke.

@en

P2093

Georgina Braganza

http://www.w3.org/2001/XMLSchema#string

Neil C Thomson

http://www.w3.org/2001/XMLSchema#string

Rekha Chaudhuri

http://www.w3.org/2001/XMLSchema#string

P2860

Inhaled corticosteroids for stable chronic obstructive pulmonary disease

Mortality in relation to smoking: 50 years' observations on male British doctors

Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis

Drug interactions with smoking

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

Drug interactions with tobacco smoking. An update.

Pulmonary Langerhans'-cell histiocytosis.

Update on glucocorticoid action and resistance.

Decreased theophylline half-life in cigarette smokers.

Corticosteroid therapy in pulmonary sarcoidosis: a systematic review.

P304

95-107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1753465808089697

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19124362

http://www.w3.org/2001/XMLSchema#string